ArticlePloS one2025
Burden, and trends of breast cancer along with attributable risk factors in Gulf Cooperation Council countries from 1990 to 2019 and its projections.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- National Burden of Breast Cancer in Saudi Arabia, 1990-2023, With Forecasts to 2050: A Systematic Analysis for the Global Burden of Disease Study 2023.Evidance health sciences · 2026Article
- Optimizing second-line endocrine-based treatment in HR positive HER2 negative metastatic breast cancer: a comprehensive expert statement from the Gulf Cooperation Council Region.Frontiers in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreast cancer (BC) is a growing global public health concern, affecting millions of women worldwide. Gulf Cooperation Council (GCC) countries are no exception to this trend. Mortality rates in GCC nations are still high despite improvements in BC treatment. This article examines the changing picture of BC incidence, prevalence, and mortality in the GCC region from 1990 to 2019 and predictions up to 2030. MATERIAL AND
methodUsing data from the Global Burden of Disease study, we analyzed BC incidence, prevalence, and mortality rates per 100,000 individuals across different age groups and countries.
resultsThe study reveals a significant rise in Age-Standardized Incidence Rates (ASIR) for breast cancer among females in Saudi Arabia from 1990 to 2019, with Oman experiencing the highest increase and Kuwait the highest decrease. Bahrain also saw a significant increase in male Age-standardized death rate (ASDR), despite all other countries experiencing a decrease. Also, the data demonstrated a statistically significant positive correlation between ASIR and Human Development Index (HDI), evident across all countries. Metabolic risk and tobacco use were identified as primary contributors. A ten-year BC prediction predicts a significant increase in female cases, with Saudi Arabia expected to experience the highest rise.
conclusionThis study underscores the urgent need for improved BC awareness, early detection through screening programs, enhanced access to quality healthcare services, and the addressing of sociocultural barriers in the GCC countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.